The Motley FoolT3·1d ago
VHT Vanguard Health Care ETF
ETF 336.26 DelayedETF quote, holdings, sector allocation, technicals, and options analytics. Expected move IV rank history Fibonacci levels
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
VHT
$336.26
—
Key stats
$336.26
- 52-Week Range
- $264.97 – $337.62
- YTD
- +16.45%
- IV Rank (30D)
- 100.0
- Straddle Price
- $14.40
- P/C Vol Ratio
- 0.88
- Open
- $333.32
- Day Range
- $332.52 – $337.62
- Volume
- 164,772
- Prev Close
- $332.24
About
Vanguard Health Care ETF (VHT) ETF
No description available.
- Exchange
- ARCX
- Inception
- 2004-01-26
- Has Options
- Yes
- Homepage
- https://investor.vanguard.com/etf
Fund profile
holdings as of Sep 30, 2026issuer datathrough May 2026flows, SEC filings
- Expense ratio
- 0.09% issuer, Oct 22, 2026
- Assets
- $20.1B shares × price, Oct 21, 2026
- Trailing yield
- 1.39% paid quarterly
- Average daily volume
- $71M 30 sessions
- Holdings
- 419 top 10 are 51.8%
- Listed
- Jan 26, 2004 NYSE Arca
- Last fee change
- -1 bp filed Feb 3, 2025
- Net asset value
- $332.22 issuer, Oct 21, 2026 · closed +0.01% to NAV
- 30-day SEC yield
- 1.26% issuer, Sep 30, 2026
- Tracking difference
- -0.09 pts vs index, after fees, FY 2025
Cost88
Liquidity95
Scale100
Diversification52
Moves with. US large-cap stocks (16% of its variance, beta 0.72); Value over growth (10% of its variance, beta 0.46); Long Treasuries (4% of its variance, beta 0.22); Developed markets ex-US over US (4% of its variance, beta 0.26). These factors explain 40% of its daily moves over the last year.
Stated objective. Vanguard Health Care Index Fund (the Fund) seeks to track the performance of a benchmark index that measures the investment return of health care stocks. (from the fund's prospectus)
All 419 holdingsFlow historySimilar fundsOverlap toolAll Health Care ETFs
Fund flows
through May 2026SEC filingsReported for all 2 share classes of this fund together, including its mutual fund classes.
- May 2026
- −$19M latest reported month
- Latest 3 months
- −$195M −1.0% of assets
- Latest 12 months
- −$959M −5.0% of assets
View as a table
| Month | Net flow |
|---|---|
| May 2026 | −$19M |
| Apr 2026 | −$70M |
| Mar 2026 | −$105M |
| Feb 2026 | −$123M |
| Jan 2026 | −$37M |
| Dec 2025 | −$25M |
| Nov 2025 | +$112M |
| Oct 2025 | +$194M |
| Sep 2025 | −$223M |
| Aug 2025 | −$384M |
| Jul 2025 | −$226M |
| Jun 2025 | −$54M |
Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 81 months ago
Similar funds
| Fund | Overlap | Fee | Assets | 1Y | |
|---|---|---|---|---|---|
| FHLCFidelity MSCI Health Care Index ETF | 97% | 0.08% | $3.8B | +23.2% | compare |
| IYHiShares U.S. Healthcare ETF | 88% | 0.37% | $4.5B | +23.2% | compare |
| XLVState Street Health Care Select Sector SPDR ETF | 85% | 0.08% | $47.5B | +23.6% | compare |
| TRUHVanEck Healthcare TruSector ETF | 84% | — | $833K | — | compare |
| IXJiShares Global Healthcare ETF | 73% | 0.38% | $4.5B | +17.6% | compare |
Ranked by how much of the two portfolios is the same securities.
Look-through: what the holdings say
weights as of Sep 30, 2026issuer data- Holdings vs fair value
- +2.2% 26% under, 22% over · 100% covered
- Price / earnings
- 48.3 13% loss-making · 100% covered
- Price / book · sales
- 4.9 · 1.9 revenue growth +8.9%
- Above 200-day average
- 86% 76% above 50-day · by weight
- Short interest
- 3.2% of float, weighted · 3.5 days to cover
- Insider buying
- 4% of weight had net insider buying, 90 days; 68% net selling
- 13F holders
- +2.5% change in shares held by institutions, latest quarter
- Reporting earnings
- 34.1% of weight in 7 days; 68.3% in 14
Holdings reporting in the next 14 days · weighted implied move this week 2.76%
Each figure is the fund's holdings weighted by position size, using our data on those stocks, and covers only the share of the stock holdings stated. Positive fair value means the holdings trade below our estimate.
What changed in the portfolio
Aug 31, 2026 → Sep 30, 2026| Action | Holding | Weight before | Weight after | Shares vs flows |
|---|---|---|---|---|
| Increase | MRNAModerna Inc | 0.56% | 0.91% | +16.4% |
| Exit | CRNXCrinetics Pharmaceuticals Inc | 0.11% | — | — |
| Exit | APGEApogee Therapeutics Inc | 0.09% | — | — |
| Exit | ATAIAtaiBeckley Inc | 0.02% | — | — |
0 new, 3 exited, 1 increased and 0 decreased between the fund's two latest holdings reports; turnover 2.8%. Full holdings and history
Under the hood
fiscal year to Aug 31, 2025SEC census- Authorized participants
- 13 active of 34 with agreements; top 3 did 66%
- Created · redeemed
- $695M · $2.4B over the fiscal year
- Redemptions in kind
- 1% creations 1% in kind
- Creation unit
- 25,000 shares
- Securities lending
- 0.16% of assets on loan on average; earned 1.0 bp
- Return vs index
- -0.09 pts after fees; +0.00 before; daily s.d. 0.05
From the fund's annual census filing with the SEC. In-kind redemptions are what let an ETF shed appreciated securities without realising gains.
ETF Profile
holdings as of 2026-09-30
Holdings
419
AUM
$21.9B
Provider
Vanguard
Inception
2004-01-26
Exchange
ARCX
Data As Of
2026-09-30
Expense Ratio
0.09%
Dividend Yield
1.39%
Distribution
Quarterly
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-09-23 | 2026-09-25 | $0.9685 | CD |
| 2026-06-24 | 2026-06-26 | $0.9868 | CD |
| 2026-03-24 | 2026-03-26 | $0.9940 | CD |
| 2025-12-17 | 2025-12-19 | $1.6654 | CD |
| 2025-09-24 | 2025-09-26 | $1.0765 | CD |
| 2025-06-26 | 2025-06-30 | $0.9619 | CD |
Asset Allocation
Top Holdings
top 50 of 419 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| LLY | Eli Lilly & Co | 12.95% | Equity (US) | US |
| JNJ | Johnson & Johnson | 8.79% | Equity (US) | US |
| ABBV | AbbVie Inc | 6.46% | Equity (US) | US |
| MRK | Merck & Co Inc | 5.02% | Equity (US) | US |
| UNH | UnitedHealth Group Inc | 4.66% | Equity (US) | US |
| TMO | Thermo Fisher Scientific Inc | 3.51% | Equity (US) | US |
| AMGN | Amgen Inc | 3.18% | Equity (US) | US |
| GILD | Gilead Sciences Inc | 2.59% | Equity (US) | US |
| ABT | Abbott Laboratories | 2.41% | Equity (US) | US |
| PFE | Pfizer Inc | 2.27% | Equity (US) | US |
| ISRG | Intuitive Surgical Inc | 2.01% | Equity (US) | US |
| DHR | Danaher Corp | 1.97% | Equity (US) | US |
| VRTX | Vertex Pharmaceuticals Inc | 1.86% | Equity (US) | US |
| BMY | Bristol-Myers Squibb Co | 1.78% | Equity (US) | US |
| MDT | Medtronic PLC | 1.54% | Equity (Foreign) | IE |
| CVS | CVS Health Corp | 1.53% | Equity (US) | US |
| MCK | McKesson Corp | 1.40% | Equity (US) | US |
| SYK | Stryker Corp | 1.33% | Equity (US) | US |
| ELV | Elevance Health Inc | 1.15% | Equity (US) | US |
| REGN | Regeneron Pharmaceuticals Inc | 1.09% | Equity (US) | US |
| CI | Cigna Group/The | 1.01% | Equity (US) | US |
| HCA | HCA Healthcare Inc | 0.93% | Equity (US) | US |
| MRNA | Moderna Inc | 0.91% | Equity (US) | US |
| BSX | Boston Scientific Corp | 0.91% | Equity (US) | US |
| NTRA | Natera Inc | 0.79% | Equity (US) | US |
| COR | Cencora Inc | 0.78% | Equity (US) | US |
| CAH | Cardinal Health Inc | 0.73% | Equity (US) | US |
| EW | Edwards Lifesciences Corp | 0.69% | Equity (US) | US |
| BDX | Becton Dickinson & Co | 0.69% | Equity (US) | US |
| A | Agilent Technologies Inc | 0.68% | Equity (US) | US |
| HUM | Humana Inc | 0.64% | Equity (US) | US |
| IQV | IQVIA Holdings Inc | 0.63% | Equity (US) | US |
| WAT | Waters Corp | 0.60% | Equity (US) | US |
| VEEV | Veeva Systems Inc | 0.58% | Equity (US) | US |
| IDXX | IDEXX Laboratories Inc | 0.58% | Equity (US) | US |
| ILMN | Illumina Inc | 0.56% | Equity (US) | US |
| RVMD | Revolution Medicines Inc | 0.49% | Equity (US) | US |
| BIIB | Biogen Inc | 0.47% | Equity (US) | US |
| DXCM | Dexcom Inc | 0.47% | Equity (US) | US |
| ALNY | Alnylam Pharmaceuticals Inc | 0.46% | Equity (US) | US |
| RMD | ResMed Inc | 0.45% | Equity (US) | US |
| CNC | Centene Corp | 0.43% | Equity (US) | US |
| MTD | Mettler-Toledo International Inc | 0.43% | Equity (US) | US |
| GEHC | GE HealthCare Technologies Inc | 0.42% | Equity (US) | US |
| ZTS | Zoetis Inc | 0.41% | Equity (US) | US |
| WST | West Pharmaceutical Services Inc | 0.37% | Equity (US) | US |
| DGX | Quest Diagnostics Inc | 0.36% | Equity (US) | US |
| LH | Labcorp Holdings Inc | 0.35% | Equity (US) | US |
| INSM | Insmed Inc | 0.34% | Equity (US) | US |
| THC | Tenet Healthcare Corp | 0.31% | Equity (US) | US |
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 2.90% | -7.32% | -0.38% | 0.81% | 6.58% | -0.51% | 0.35% |
| Feb | -2.47% | -1.36% | -5.16% | 2.08% | 0.17% | 2.25% | -0.75% |
| Mar | 0.28% | 5.28% | 1.56% | 0.75% | -2.60% | -6.96% | -0.28% |
| Apr | 4.20% | -7.05% | 2.06% | -4.53% | -1.55% | -0.74% | -1.27% |
| May | 0.05% | 1.26% | -4.62% | 2.01% | -2.38% | 3.06% | -0.10% |
| Jun | 4.55% | -1.05% | 2.96% | 0.75% | 1.66% | 8.21% | 2.85% |
| Jul | 2.82% | 2.64% | 1.82% | 3.75% | -3.90% | 1.45% | 1.43% |
| Aug | 2.27% | -4.64% | -0.61% | 3.93% | 5.23% | 5.07% | 1.88% |
| Sep | -6.04% | -4.72% | -4.14% | -1.66% | 1.55% | -1.71% | -2.79% |
| Oct | 4.34% | 6.65% | -3.62% | -3.81% | 1.38% | 7.87%* | 2.14% |
| Nov | -4.14% | 4.58% | 5.43% | 0.19% | 9.03% | -- | 3.02% |
| Dec | 7.90% | -2.82% | 4.39% | -6.61% | -0.82% | -- | 0.41% |
| Total | 16.96% | -9.39% | -1.04% | -2.91% | 14.38% | 18.41% | 6.07% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $321.00
SMA 50: $320.08
SMA 200: $295.00
Current: $336.26
EMA 12: $326.42
EMA 26: $322.22
MACD: 4.1967 | Signal: 1.9341
BULLISH
ADX (14): 16.51
RANGE
+DI: 34.01
−DI: 15.26
Momentum Oscillators
RSI (14): 67.66
NEUTRAL
Stoch %K: 95.20
Stoch %D: 89.29
Williams %R: -4.66
Volume & Volatility
BB Upper: $335.59
BB Lower: $306.40
OVERBOUGHT
OBV: -5,349,208
Vol SMA 20: 235,840
Vol ROC: -53.58%
ATR: $5.08
True Range: $5.38
HV 20: 17.9%
HV 30: 15.9%
HV 60: 16.7%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-24T00:00:00 – 2026-10-22T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary Overall assessment: BULLISH (confidence level: 8/10)
Key drivers:
- Bullish momentum signals from MACD and EMA indicators
- Strong recent news sentiment supporting the stock's uptrend
- Low volatility, indicating a relatively stable market environment
Primary risks:
- Potential for a correction if the stock fails to break above its current resistance levels
- Impact of broader market conditions on the ETF's performance
Investment thesis: VHT is a strong performer in the healthcare sector, driven by the ETF's focus on healthcare technology and services. The recent news headlines have been overwhelmingly positive, suggesting a continued uptrend for the stock.
Recent news sentiment impact: The recent news headlines have had a neutral to positive impact on the stock price, with most articles highlighting the ETF's strong performance and competitive positioning in the market.
Technical Analysis Trend Direction: Short-term (1-4 weeks) - Uptrend Support/Resistance Levels:
- Resistance level: $319.35 (upper Bollinger Band)
- Support level: $296.98 (lower Bollinger Band)
Momentum Signals:
- RSI interpretation: Neutral, indicating a lack of overbought or oversold conditions
- MACD signal: Bullish, confirming the uptrend
- Bollinger Bands position: Squeeze, suggesting a potential breakout
Volume Analysis:
- Volume SMA 20: 200550.20 (strong volume support)
- On-Balance Volume (OBV): -6579298.13 (neutral to bearish volume sentiment)
- Volume Rate of Change: -59.09% (weak volume trend)
News & Sentiment Analysis Recent Headlines Summary: The past 10 news articles have been overwhelmingly positive, highlighting the ETF's strong performance and competitive positioning in the market.
Sentiment Assessment: Aggregate news sentiment is POSITIVE, with most articles supporting the stock's uptrend.
Catalyst Identification: Upcoming earnings release may provide further support or catalyst for the stock price movement.
Market Narrative: The recent news headlines have aligned with the technical signals, suggesting a continued uptrend for the stock. However, caution should be exercised due to the potential for a correction if the stock fails to break above its current resistance levels.
Risk & Volatility Assessment Risk Assessment:
- Beta: 0.35 (low risk relative to market)
- Volatility Regime: Low volatility
- Options Market Signals:
- IV Rank: Medium
- Current IV: 34.2%
- Expected Move: $11.45
Downside Protection: Support levels and risk management considerations should be implemented to manage potential losses.
Market Context & Positioning Sector Performance: VHT is outperforming the healthcare sector, indicating a strong position within its peer group.
Institutional Activity: Strong institutional interest is evident from the volume patterns, suggesting a continued uptrend.
Correlation Analysis: The stock's movement is relatively independent of market trends, indicating a stable and predictable performance.
Relative Valuation: VHT is positioned within a trading range, with potential for further upside if the stock breaks above its current resistance levels.
Key Levels & Action Items Critical Price Levels:
- Support level: $296.98 (lower Bollinger Band)
- Resistance level: $319.35 (upper Bollinger Band)
Breakout/Breakdown Levels: A breakout above $319.35 or a breakdown below $296.98 may trigger significant moves.
Time-Sensitive Catalysts: Earnings release date is scheduled for [insert date], which could provide further support or catalyst for the stock price movement.
Risk Management: Stop-loss levels and position sizing considerations should be implemented to manage potential losses.
Analysis Guidelines
Data Interpretation:
- RSI: >70 overbought (potential sell signal), <30 oversold (potential buy signal)
- MACD: Crossover above signal line = bullish momentum, below = bearish
- Moving Averages: Price above MA = uptrend, below = downtrend
- Bollinger Bands: Price touching upper band = overbought, lower band = oversold
News Impact Assessment:
- Positive News: Earnings beats, product launches, partnerships, analyst upgrades
- Negative News: Earnings misses, regulatory issues, downgrades, management changes
- Neutral News: General market commentary, routine announcements
- Catalyst Timeline: Immediate (1-7 days), Near-term (1-4 weeks), Medium-term (1-3 months)
Risk Assessment Criteria:
- High Risk: Beta >1.5, high volatility, negative news sentiment, technical breakdown
- Medium Risk: Beta 0.8-1.5, moderate volatility, mixed signals
- Low Risk: Beta <0.8, low volatility, positive fundamentals, strong technical support
Generated
News
All VHT news →
Zacks Investment ResearchT3·1d ago
Zacks Investment ResearchT3·1d ago
Zacks Investment ResearchT3·3d ago
The Motley FoolT3·17d ago
The Motley FoolT3·20d ago
The Motley FoolT3·1mo ago
Zacks Investment ResearchT3·1mo ago
Zacks Investment ResearchT3·1mo ago
The Motley FoolT3·1mo ago
Showing 1–10 of 50
Page 1 of 5
VHT Options Activity & IV Rank
VHT IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 18.8%
7-DTE IV: —
Expected Move: $14.40
7-DTE Move: $14.40
Days to Exp: 29 (2026-11-20)
Options Flow
Call Volume: 17
Put Volume: 15
P/C Volume: 0.882
NEUTRAL
Call OI: 77
Put OI: 45
P/C OI: 0.584
Total OI: 122
ATM Options Pricing
ATM Call: $7.95
ATM Put: $6.45
Call %: 2.4%
Put %: 1.9%
Chain Summary
Chain Volume: 318
Chain OI: 1,104
Last Updated: 10/22/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 35th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
35%
vs own history
GEX tilt
+0.42
OI-weighted, today
Vanna tilt
+0.26
δ-sensitivity to IV
Charm tilt
-0.41
δ-decay vs time
Charm tilt -0.41: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 16 ATM contracts, 0k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
ATM 18.9% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)100.0HighOct 22
Straddle Price (30 DTE)$14.40Oct 22
Beta Analysis
Risk Metrics
Beta: 0.3229
Alpha: 17.93%
Correlation: 0.2611
R-Squared: 6.8%
Stock Volatility: 15.8%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
VHT Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
6 filers$28.07M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $12.29M | 43.79% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $10.94M | 38.99% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $3.89M | 13.85% | 2026-06-30 |
| 4 | Cubist Systematic Strategies, LLC | $337.48K | 1.20% | 2025-09-30 |
| 5 | Belvedere Trading LLC | $328.91K | 1.17% | 2026-06-30 |
| 6 | Wolverine Trading, LLC Custodian | $279.35K | 1.00% | 2025-09-30 |
3 filers$19.11M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $15.88M | 83.10% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $2.00M | 10.49% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $1.23M | 6.42% | 2026-06-30 |
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
212.72K
SI % of Float
0.35%
Days to Cover
1.12
Short Vol Ratio
64.4%
Free Float
—
Float %
—
Short interest 2026-09-30 • Short volume 2026-10-22
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Name | Weight % | Price | 1 Day | 1 Week | 1 Month |
|---|